CytomX Therapeutics
CTMX
A$3.45
Share price
0.89%
Change (1 day)
73.30%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total debt
Total debt on the balance sheet as of March 2025 : A$12.39 Million
According to CytomX Therapeutics 's latest financial reports the company's total debt is A$12.39 Million. A company’s total debt is the sum of all current and non-current debts.
CytomX Therapeutics - Total debt on balance sheet (from 2014 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$15.08 M | -26.44% |
| 2023-12-31 | A$20.51 M | -22.7% |
| 2022-12-31 | A$26.53 M | -11.24% |
| 2021-12-31 | A$29.89 M | -7.57% |
| 2020-12-31 | A$32.34 M | -18.19% |
| 2019-12-31 | A$39.53 M | |
| 2018-12-31 | N/A | |
| 2014-12-31 | A$3.64 M | -22.54% |
| 2013-12-31 | A$4.71 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | A$4.88 M | -60.57% | 🇺🇸 USA |